Target intelligence / Profile preview

Rogdi atypical leucine zipper (ROGDI)

Target
ROGDI
Molecular classification
Other (leucine zipper-like protein, not a classical receptor/enzyme/transporter/category protein)
01

Overview

Rogdi atypical leucine zipper is a highly conserved, monomeric leucine zipper-like protein, present in metazoan organisms, encoded by the ROGDI gene on human chromosome 16[1][2][3][4][5]. Its structure comprises a unique curved architecture with a core four-helix bundle and a β-sheet domain, forming a leucine zipper-like but functionally and structurally distinct motif from classical coiled-coil ZIP proteins[1]. It is expressed at highest levels in the brain and spinal cord and is implicated in the development of the nervous system and teeth[5][3]. Mutations in ROGDI cause Kohlschutter-Tonz syndrome, a rare autosomal recessive disorder featuring epilepsy, spasticity, global developmental delay, and amelogenesis imperfecta (defective tooth enamel)[1][2][3][5]. Rogdi interacts with other neuronal proteins, including DISC1, suggesting a role for protein scaffolding in neurogenesis[1]. Despite its structural characterization, there is no evidence that Rogdi is a conventional therapeutic target such as a receptor, enzyme, ion channel, or transporter, and no drugs are currently known to act on Rogdi[1][2].

Other names
RogdiROGDI proteinLeucine zipper protein rogdi
02

Biological functions

Brain developmentNeurogenesisOdontogenesis (tooth development, specifically dentin-containing tooth formation)Putative roles in neuronal proliferation, migration, and differentiation (by interaction with DISC1)Implicated in protein–protein interaction scaffolding
03

Disease associations

Neurodevelopmental disorders (notably Kohlschutter-Tonz syndrome)Other developmental syndromes (such as intellectual disability, dental anomalies)
04

Biomarkers

Loss-of-function mutations as biomarkers for Kohlschutter-Tonz syndrome diagnosis

Beyond the preview

Go deeper on Rogdi atypical leucine zipper (ROGDI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rogdi atypical leucine zipper (ROGDI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call